Screener
First Tracks Biotherapeutics Inc TRAX External Expenses — General And Administrative Expense
Other product segments
Similar metrics at other companies
Where this comes from
Reported directly by First Tracks Biotherapeutics Inc in its filing.
Tagged under the XBRL concept us-gaap:GeneralAndAdministrativeExpense.
The source filing: First Tracks Biotherapeutics Inc’s 10-Q, filed May 14, 2026.
- Filed
- May 14, 2026, 4:32 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-224190
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Total External R&D(1) | 18,642 | 27,778 |
| Total Internal R&D(2) | 15,313 | 13,687 |
| Total R&D | 33,955 | 41,465 |
| External G&A(3) | 8,721 | 3,848 |
| Internal G&A(2) | 10,135 | 5,967 |
| Total G&A | 18,856 | 9,815 |
| Total operating expenses | 52,811 | 51,280 |
| Loss from operations | (52,811) | (51,280) |
Item 1. Combined Financial Statements.
FAQ
- What is First Tracks Biotherapeutics Inc's external expenses — general and administrative expense?
- First Tracks Biotherapeutics Inc (TRAX) reported external expenses — general and administrative expense of $8.72M in Q1 2026.
- What does external expenses — general and administrative expense mean?
- This metric represents the portion of general and administrative (G&A) expenses that are attributed to external service providers, consultants, or third-party vendors rather than internal payroll and overhead. It captures the costs associated with outsourcing essential business support functions, such as legal, accounting, or specialized administrative advisory services. Monitoring this helps investors understand the company's reliance on external expertise versus internal capacity for operational management.
Ask your AI about First Tracks Biotherapeutics Inc's external expenses — general and administrative expense.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude